MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Multiple Sclerosis Journal
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

655 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
655 works in the cohort · of 4,299,418page 9 of 14

Labels cover 3 of 655 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 655 of 655 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Efficacy and safety results after >3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study
Xavier Montalbán, Karolina Piasecka‐Stryczynska, Jens Kühle, Pascal Benkert, Douglas L. Arnold, Martin S. Weber +8 more
2024· article· en· Multiple Sclerosis Journal· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
16
citations
affunlabeled
Biosensors to monitor MS activity
Jennifer Graves, Xavier Montalbán
2020· review· en· Multiple Sclerosis Journal· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · none
15
citations
afffundunlabeled
Three-dimensional MRI sequences in MS diagnosis and research
Leo Hu, Luckshi Rajendran, Emmanuelle Lapointe, Roger Tam, David Li, Anthony Traboulsee +1 more
2019· review· en· Multiple Sclerosis Journal· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
14
citations
aboutno affunlabeled
Copy number variation in pediatric multiple sclerosis
J T McElroy, Lauren Krupp, Britt Johnson, Jacob L. McCauley, Zhigang Qi, SJ Caillier +8 more
2012· article· en· Multiple Sclerosis Journal· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
14
citations
affunlabeled
Methods and measures: what’s new for MS?
Nancy E. Mayo, Stanley Hum, Ayse Kuspinar
2012· review· en· Multiple Sclerosis Journal· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
14
citations
affunlabeled
An introduction to the microbiome and MS
Sebastien Trott, Irah L. King
2018· article· en· Multiple Sclerosis Journal· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
13
citations
affno abstractunlabeled
Slowly expanding lesions are a marker of progressive MS – No
Douglas L. Arnold, Shibeshih Belachew, Arie Gafson, Laura Gaetano, Corrado Bernasconi, Colm Elliott
2021· article· en· Multiple Sclerosis Journal· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
13
citations
← previousnext →

How this was built: Screen · Findings · About